COEP - Coeptis Therapeutics Holdings, Inc.

16.4
0.190   1.159%

Share volume: 107,794
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.21%

PREVIOUS CLOSE
CHG
CHG%
$16.21
0.19
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 30%
Liquidity 46%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.53%
1 Month
46.56%
3 Months
17.73%
6 Months
9.04%
1 Year
112.99%
2 Year
4,993.17%
Key data
Stock price
$16.40
P/E Ratio 
N/A
DAY RANGE
$15.87 - $17.27
EPS 
-$7.00
52 WEEK RANGE
$6.80 - $21.41
52 WEEK CHANGE
$82.83
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
6.223 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-31-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
1.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$81,147
AVERAGE 30 VOLUME 
$55,820
Company detail
CEO: David Mehalick
Region: US
Website: coeptispharma.com
Employees: 2
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded in 2018 and is based in Miami Beach, Florida.

Recent news